Peng joins Denali as chief commercial officer

Denali Therapeutics Inc. (NASDAQ:DNLI) hired Katie Peng as chief commercial officer, a newly created role at the neurodegenerative disease company. Peng most recently served as SVP and head of ophthalmology, metabolism, neuroscience and immunology business unit at the Genentech unit of Roche (SIX:ROG; OTCQX:RHHBY). 

Synthetic DNA company Twist Bioscience Corp. (NASDAQ:TWST) hired Dennis Cho as SVP, general counsel, and chief ethics and compliance officer. Cho was most recently assistant general counsel at CytomX Therapeutics Inc. (NASDAQ:CTMX)...